Rare diseases are complex and perplexing to medical science. The low prevalence, diversity and limited knowledge, makes it very challenging to recruit subjects into a clinical trial. Rare diseases adds a significant burden on mankind with 80% of rare diseases being genetic in nature and 50% of these conditions being diagnosed in children.In Japan too, […]

The word ‘cancer’ looms fear and uncertainty in the minds of people. This statement has a certain degree of validation with cancer having advanced as the number one cause of fatality in Japan. Although cancer mortality has declined in the young population, the mortality rates have significantly risen among the elderly population. The last decade […]

Every subject adds value to a clinical trial. Patient recruitment and retention are key aspects for the successful completion of a clinical trial. A high dropout rate can lead to a wastage of time, money and effort where any pharmaceutical company will not be able to gather prime data of primary outcomes in a clinical […]

The optimal functioning of genes in our body is essential for our wellbeing. However, there is a probability that we might inherit a defective gene which codes for a certain illness. This is sure to leave you frustrated. Not anymore though – gene therapy is advancing rapidly to prevent and treat such disabilities. Through unending […]

The clinical research industry thrives on efficient patient recruitment and retention. One of the most challenging aspects in a randomised controlled trial is reaching the set target patient population. Poor recruitment figures questions the financial and scientific viability of a clinical trial. If the estimated sample size of a clinical trial is not met, then […]

3H Medi Solution is continuously trying to adopt novel ways to make Clinical trial conduct more efficient and innovative. This has brought about a new facelift to the industry in Japan, with bio-pharma companies being open to having the general population participate in the trial process in formulating protocols and generating data. 3H as a […]

Dr. Jun Ishigooka, a prominent professor in psychopharmacology attached to Tokyo’s Women’s Medical University School of Medicine has given a great insight into the current trends in drug development for depression and has feedback has added value to this blog post. Depression can affect anyone and it is becoming increasingly common in today’s fast moving […]

In the fast-changing, dynamic healthcare structure, the voice of the patient is becoming increasingly powerful. It’s clear to the pharma world today, that it’s important to have their health practices aligned to enhance consumer experience while adding value to their patients to remain competitive in the market. In this era of digitalisation, the patients have […]

The Asian clinical trial market is expanding rapidly and has now become the main go-to destination for pharmaceutical companies, who are looking to outsource their clinical trials. A large treatment naïve population, together with friendly market reforms and as a region with a high disease burden, it has made Asia a preferred choice today, than […]

In the rapidly changing world of modern healthcare that has been revolutionized by the integration of technology, the pharmaceutical industry is facing an unprecedented number of problems and constraints, which can be seen in the infographic below. In the face of such huge hurdles, it becomes imperative for the medical industry to leverage the use […]